Cover Image
市場調查報告書

全球青春痘市場

Global Acne Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 318282
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
全球青春痘市場 Global Acne Market 2014-2018
出版日期: 2014年11月05日 內容資訊: 英文 72 Pages
簡介

青春痘,是常見的皮膚疾病之一。青春痘(尋常痤瘡),是皮膚的發炎性疾病,影響大部分的年齡層。青春痘的正確病因,尚未完全清楚。青春痘對健康來說不是重大的威脅,不過,嚴重的青春痘,不僅伴隨疼痛,也影響患者的生活品質(QOL)。青春痘可利用的治療藥選項,有外用製劑,口服藥,或所有的組合。全球青春痘市場,預計2013年∼2018年以4.07%的CAGR成長。

本報告提供全球青春痘市場相關調查分析、市場規模與成長率、市場趨勢、推動市場要素與課題、關於市場機會驗證、主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測

第7章 青春痘的意義

  • 波特的五力分析

第8章 青春痘的種類與特徵

第9章 上市產品的競爭評估

第10章 發病率和患者數

  • 美國
  • 英國

第11章 市場區隔:各類別

第12章 地區區分

第13章 購買標準

第14章 推動市場成長要素

第15章 推動因素與其影響

第16章 市場課題

第17章 推動因素與課題的影響

第18章 市場趨勢

第19章 趨勢與其影響

第20章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他卓越供應商

第21章 主要供應商分析

  • Actavis plc
  • Allergan Inc.
  • Galderma
  • Stiefel Laboratories
  • Valeant Pharmaceuticals International Inc.

第22章 相關報告

圖表

目錄
Product Code: IRTNTR4570

About Acne

Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient's quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne.

TechNavio's analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018.

Covered in this Report

The Global Acne market can be divided into seven segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.

TechNavio's report, the Global Acne Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Acne market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Actavis
  • Allergen
  • Galderma
  • Stiefel Laboratories
  • Valeant Pharmaceuticals International

Other Prominent Vendors

  • Andro Science
  • Bayer
  • Cipher Pharmaceuticals
  • Cosmo Pharmaceuticals
  • Elorac
  • Foamix Pharmaceuticals
  • Helix BioMedix
  • Hygeia Therapeutics
  • IMTM
  • J&J
  • Mylan Pharmaceuticals
  • NanoBio
  • NovaLead Pharma
  • F. Hoffmann-La Roche

Market Driver

  • Significant Unmet Needs
  • For a full, detailed list, view our report

Market Challenge

  • High Cost of Acne Drugs
  • For a full, detailed list, view our report

Market Trend

  • Increased Focus on Combination Therapies
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast

07. Implications of Acne

  • 07.1. Five Forces Analysis

08. Types and Characteristics of Acne

09. Competitive Assessment of Marketed Products

10. Rate of Incidence and Prevalence

    • 10.1.1. US
    • 10.1.2. UK

11. Market Segmentation by Category

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
    • 20.1.1. Key News
    • 20.1.2. Mergers and Acquisitions
  • 20.2. Market Share Analysis 2013
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. Actavis plc
    • 21.1.1. Key Facts
    • 21.1.2. Business Description
    • 21.1.3. Business Segmentation
    • 21.1.4. Business Segmentation by Revenue 2012 and 2013
    • 21.1.5. Sales by Geography
    • 21.1.6. Business Strategy
    • 21.1.7. Key Information
    • 21.1.8. SWOT Analysis
  • 21.2. Allergan Inc.
    • 21.2.1. Key Facts
    • 21.2.2. Business Description
    • 21.2.3. Business Segmentation
    • 21.2.4. Revenue by Business Segmentation
    • 21.2.5. Revenue Comparison 2011-2013
    • 21.2.6. Revenue by Geographical Segmentation
    • 21.2.7. Business Strategy
    • 21.2.8. Key Developments
    • 21.2.9. SWOT Analysis
  • 21.3. Galderma
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Product Segmentation by Revenue 2013
    • 21.3.4. Geographical Segmentation by Revenue 2013
    • 21.3.5. Business Strategy
    • 21.3.6. Recent Developments
    • 21.3.7. SWOT Analysis
  • 21.4. Stiefel Laboratories
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Product Segmentation
    • 21.4.4. Geographical Segmentation by Revenue 2013
    • 21.4.5. Business Strategy
    • 21.4.6. Recent Developments
    • 21.4.7. SWOT Analysis
  • 21.5. Valeant Pharmaceuticals International Inc.
    • 21.5.1. Key Facts
    • 21.5.2. Business Overview
    • 21.5.3. Business Segmentation by Revenue 2013
    • 21.5.4. Business Segmentation by Revenue 2012 and 2013
    • 21.5.5. Sales by Geography
    • 21.5.6. Business Strategy
    • 21.5.7. Key Developments
  • 21.6. SWOT Analysis

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Acne Market 2013-2018 (US$ billion)
  • Exhibit 4: Global Acne Market Segmentation by Category
  • Exhibit 5: Global Acne Market by Geographical Segmentation 2013
  • Exhibit 6: Allergen Sales by Portfolio 2012
  • Exhibit 7: Galderma Sales by Therapeutic Area 2012
  • Exhibit 8: Global Acne marketBusiness Segmentation 2013
  • Exhibit 9: Global Acne market Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 10: Actavis Plc: Sales by Geography (in US$ million)
  • Exhibit 11: Allergan Inc.: Business Segmentation
  • Exhibit 12: Allergan Inc.: Revenue by Business Segmentation 2013
  • Exhibit 13: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
  • Exhibit 14: Allergan Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 15: Galderma: Product Segmentation by Revenue 2013
  • Exhibit 16: Galderma: Geographical Segmentation by Revenue 2013
  • Exhibit 17: Stiefel Laboratories: Product Segmentation 2013
  • Exhibit 18: Stiefel Laboratories: Geographical Segmentation by Revenue 2013
  • Exhibit 19: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2013
  • Exhibit 20: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 21: Valeant Pharmaceuticals International Inc.: Sales by Geography 2013
Back to Top